Skip to Main Content

Paper Details

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19.
J Am Heart Assoc
61
2021
ACE, Angiotensin Receptor, Angiotensin-Converting Enzyme, COVID-19, Hypertensive, Patients, SARS, SARS-CoV, angiotensin receptor, angiotensin-converting enzyme, coronavirus, coronavirus 2 infection, hypertension, severe acute respiratory syndrome
Author NameAffiliation
Rohan KheraSection of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.
Rohan KheraCenter for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.
Rohan KheraSection of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.
Rohan KheraCenter for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.
Yuan LuSection of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.
Yuan LuCenter for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.
Erica S SpatzSection of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.
Erica S SpatzCenter for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.
Karthik MurugiahSection of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.
Karthik MurugiahCenter for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.
Zhenqiu LinSection of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.
Zhenqiu LinCenter for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.
Saad B OmerSection of Infectious Diseases Department of Internal Medicine Yale School of Medicine New Haven CT.
Saad B OmerYale Institute for Global Health New Haven CT.
Saad B OmerDepartment of Epidemiology of Microbial Diseases Yale School of Public Health New Haven CT.
Harlan M KrumholzSection of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.
Harlan M KrumholzCenter for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.
Harlan M KrumholzDepartment of Health Policy and Management Yale School of Public Health New Haven CT.
Harlan M KrumholzSection of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.
Harlan M KrumholzCenter for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT.
Harlan M KrumholzDepartment of Health Policy and Management Yale School of Public Health New Haven CT.
  • 1 - 21

Datasets